识别未经批准的骨科再生医学：再生医学安全法的实用性。
Identification of unapproved orthopedic regenerative medicine: Usefulness of the Act on Safety of Regenerative Medicine.
机构信息
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Department of Obstetrics and Gynecology, Jikei University School of Medicine, 3-25-8, Nishishinbashi, Minato, Tokyo 105-8461, Japan.
出版信息
Stem Cell Reports. 2024 May 14;19(5):597-603. doi: 10.1016/j.stemcr.2024.04.001. Epub 2024 May 2.
In Japan, the Act on Safety of Regenerative Medicine regulates unapproved regenerative medicine. Other nations market regenerative medicine products, bypassing regulatory approval. To identify unapproved orthopedic regenerative medicine, we have used data based on the Act. Platelet-rich plasma was often used. The common target was the knee. Prices averaged $2,490.
在日本，《再生医学安全法》规范了未经批准的再生医学。其他国家则绕过监管批准，销售再生医学产品。为了确定未经批准的骨科再生医学，我们使用了基于该法的数据。富血小板血浆经常被使用。常见的目标是膝盖。价格平均为 2490 美元。
Zotero 插件